{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:59:51Z","timestamp":1791849591209,"version":"4.3.4"},"reference-count":53,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2020.0320","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:53:20Z","timestamp":1587966800000},"source":"Crossref","is-referenced-by-count":29,"title":["Coronary Stent Thrombosis \u2014 Predictors and Prevention"],"prefix":"10.3238","author":[{"given":"Helen","family":"Ullrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"10.3238\/arztebl.2020.0320_ref1","doi-asserted-by":"crossref","unstructured":"Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD: Stent thrombosis: a clinical perspective. JACC Cardiovasc Interv 2014; 7: 1081\u201392","DOI":"10.1016\/j.jcin.2014.05.016"},{"key":"10.3238\/arztebl.2020.0320_ref2","doi-asserted-by":"crossref","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126\u201330","DOI":"10.1001\/jama.293.17.2126"},{"key":"10.3238\/arztebl.2020.0320_ref3","doi-asserted-by":"crossref","unstructured":"Lemesle G, Tricot O, Meurice T, et al.: Incident myocardial infarction and very late stent thrombosis in outpatients with stable coronary artery disease. J Am Coll Cardiol 2017; 69: 2149\u201356","DOI":"10.1016\/j.jacc.2017.02.050"},{"key":"10.3238\/arztebl.2020.0320_ref4","doi-asserted-by":"crossref","unstructured":"Cutlip DE, Windecker S, Mehran R, et al.: Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344\u201351","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"10.3238\/arztebl.2020.0320_ref5","doi-asserted-by":"crossref","unstructured":"D\u2018Ascenzo F, Bollati M, Clementi F, et al.: Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol 2013; 167: 575\u201384","DOI":"10.1016\/j.ijcard.2012.01.080"},{"key":"10.3238\/arztebl.2020.0320_ref6","doi-asserted-by":"crossref","unstructured":"Cuculi F, Puricel S, Jamshidi P, et al.: Optical coherence tomography findings in bioresorbable vascular scaffolds thrombosis. Circ Cardiovasc Interv 2015; 8: e002518","DOI":"10.1161\/CIRCINTERVENTIONS.114.002518"},{"key":"10.3238\/arztebl.2020.0320_ref7","doi-asserted-by":"crossref","unstructured":"Byrne RA, Joner M, Kastrati A: Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014. Eur Heart J 2015; 36: 3320\u201331","DOI":"10.1093\/eurheartj\/ehv511"},{"key":"10.3238\/arztebl.2020.0320_ref8","doi-asserted-by":"crossref","unstructured":"Sch\u00f6mig A, Neumann FJ, Kastrati A, et al.: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084\u20139","DOI":"10.1056\/NEJM199604253341702"},{"key":"10.3238\/arztebl.2020.0320_ref9","doi-asserted-by":"crossref","unstructured":"Leon MB, Baim DS, Popma JJ, et al.: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent anticoagulation restenosis study investigators. N Engl J Med 1998; 339: 1665\u201371","DOI":"10.1056\/NEJM199812033392303"},{"key":"10.3238\/arztebl.2020.0320_ref10","doi-asserted-by":"crossref","unstructured":"Kedhi E, Joesoef KS, McFadden E, et al.: Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 2010; 375: 201\u20139","DOI":"10.1016\/S0140-6736(09)62127-9"},{"key":"10.3238\/arztebl.2020.0320_ref11","doi-asserted-by":"crossref","unstructured":"Ali ZA, Gao R, Kimura T, et al.: Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials. Circulation 2018; 137: 464\u201379","DOI":"10.1161\/CIRCULATIONAHA.117.031843"},{"key":"10.3238\/arztebl.2020.0320_ref12","doi-asserted-by":"crossref","unstructured":"Polimeni A, Anadol R, M\u00fcnzel T, Indolfi C, De Rosa S, Gori T: Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs. BMC Cardiovasc Disord 2017; 17: 147","DOI":"10.1186\/s12872-017-0586-2"},{"key":"10.3238\/arztebl.2020.0320_ref13","doi-asserted-by":"crossref","unstructured":"Schulz S, Schuster T, Mehilli J, et al.: Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. Eur Heart J 2009; 30: 2714\u201321","DOI":"10.1093\/eurheartj\/ehp275"},{"key":"10.3238\/arztebl.2020.0320_ref14","doi-asserted-by":"crossref","unstructured":"Knuuti J, Wijns W, Saraste A, et al.: 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019; 00: 1\u201371. doi:10.1093\/eurheartj\/ehz425","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"10.3238\/arztebl.2020.0320_ref15","doi-asserted-by":"crossref","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al.: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213\u201360","DOI":"10.1093\/eurheartj\/ehx638"},{"key":"10.3238\/arztebl.2020.0320_ref16","doi-asserted-by":"crossref","unstructured":"Varenne O, Cook S, Sideris G, et al.: Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 2018; 391: 41\u201350","DOI":"10.1016\/S0140-6736(17)32713-7"},{"key":"10.3238\/arztebl.2020.0320_ref17","doi-asserted-by":"crossref","unstructured":"Valgimigli M, Borghesi M, Tebaldi M, et al.: Should duration of dual antiplatelet therapy depend on the type and\/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY). Eur Heart J 2013; 34: 909\u201319","DOI":"10.1093\/eurheartj\/ehs460"},{"key":"10.3238\/arztebl.2020.0320_ref18","doi-asserted-by":"crossref","unstructured":"Yeh RW, Kereiakes DJ, Steg PG, et al.: Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention. J Am Coll Cardiol 2017; 70: 2213\u201323","DOI":"10.1016\/j.jacc.2017.09.011"},{"key":"10.3238\/arztebl.2020.0320_ref19","doi-asserted-by":"crossref","unstructured":"Verdoia M, Kedhi E, Ceccon C, Suryapranata H, De Luca G: Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: a meta-analysis of 11 randomized trials. Int J Cardiol 2018; 264: 30\u20138","DOI":"10.1016\/j.ijcard.2018.02.095"},{"key":"10.3238\/arztebl.2020.0320_ref20","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al.: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS - Web Addenda. https:\/\/academic.oup.com\/DocumentLibrary\/EHJ\/SupplementaryData\/ehx419web.pdf (last accessed on 2 April 2020)."},{"key":"10.3238\/arztebl.2020.0320_ref21","doi-asserted-by":"crossref","unstructured":"Costa F, van Klaveren D, James S, et al.: Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 2017; 389: 1025\u201334","DOI":"10.1016\/S0140-6736(17)30397-5"},{"key":"10.3238\/arztebl.2020.0320_ref22","doi-asserted-by":"crossref","unstructured":"G\u00e9n\u00e9reux P, Rutledge DR, Palmerini T, et al.: Stent thrombosis and dual antiplatelet therapy interruption with everolimus-eluting stents: insights from the Xience V Coronary Stent System trials. Circ Cardiovasc Interv 2015; 8: pii: e001362","DOI":"10.1161\/CIRCINTERVENTIONS.114.001362"},{"key":"10.3238\/arztebl.2020.0320_ref23","doi-asserted-by":"crossref","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, et al.: Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009; 53: 1399\u2013409","DOI":"10.1016\/j.jacc.2008.12.055"},{"key":"10.3238\/arztebl.2020.0320_ref24","doi-asserted-by":"crossref","unstructured":"Camenzind E, Steg PG, Wijns W: Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007; 115: 1440\u201355","DOI":"10.1161\/CIRCULATIONAHA.106.666800"},{"key":"10.3238\/arztebl.2020.0320_ref25","doi-asserted-by":"crossref","unstructured":"McFadden EP, Stabile E, Regar E, et al.: Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519\u201321","DOI":"10.1016\/S0140-6736(04)17275-9"},{"key":"10.3238\/arztebl.2020.0320_ref26","doi-asserted-by":"crossref","unstructured":"Palmerini T, Biondi-Zoccai G, Della Riva D, et al.: Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393\u2013402","DOI":"10.1016\/S0140-6736(12)60324-9"},{"key":"10.3238\/arztebl.2020.0320_ref27","doi-asserted-by":"crossref","unstructured":"Jensen LO, Thayssen P, Maeng M, et al.: Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention: The SORT OUT VII Trial. Circ Cardiovasc Interv 2016; 9: pii: e003610","DOI":"10.1161\/CIRCINTERVENTIONS.115.003610"},{"key":"10.3238\/arztebl.2020.0320_ref28","doi-asserted-by":"crossref","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, et al.: 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87\u2013165","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"10.3238\/arztebl.2020.0320_ref29","doi-asserted-by":"crossref","unstructured":"Buccheri S, Franchina G, Romano S, et al.: Clinical outcomes following intravascular imaging-guided versus coronary angiography-guided percutaneous coronary intervention with stent implantation: a systematic review and bayesian network meta-analysis of\u00a031\u00a0studies and 17,882 patients. JACC Cardiovasc Interv 2017; 10: 2488\u201398","DOI":"10.1016\/j.jcin.2017.08.051"},{"key":"10.3238\/arztebl.2020.0320_ref30","doi-asserted-by":"crossref","unstructured":"Maehara A, Matsumura M, Ali ZA, Mintz GS, Stone GW: IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal. JACC Cardiovasc Imaging 2017; 10: 1487\u2013503","DOI":"10.1016\/j.jcmg.2017.09.008"},{"key":"10.3238\/arztebl.2020.0320_ref31","doi-asserted-by":"crossref","unstructured":"Souteyrand G, Amabile N, Mangin L, et al.: Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J 2016; 37: 1208\u201316","DOI":"10.1093\/eurheartj\/ehv711"},{"key":"10.3238\/arztebl.2020.0320_ref32","doi-asserted-by":"crossref","unstructured":"Sethi A, Singbal Y, Rastogi U, Prasad VS: Late incomplete stent apposition is associated with late\/very late stent thrombosis: a meta-analysis. Catheter Cardiovasc Interv 2018; 91: 365\u201375","DOI":"10.1002\/ccd.27102"},{"key":"10.3238\/arztebl.2020.0320_ref33","doi-asserted-by":"crossref","unstructured":"Jang JS, Song YJ, Kang W, et al.: Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC Cardiovasc Interv 2014; 7: 233\u201343","DOI":"10.1016\/j.jcin.2013.09.013"},{"key":"10.3238\/arztebl.2020.0320_ref34","doi-asserted-by":"crossref","unstructured":"Prati F, Romagnoli E, La Manna A, et al.: Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: the Centro Per La Lotta Contro L\u2018infarto-Optimization Of Percutaneous Coronary Intervention (CLI-OPCI) LATE study. EuroIntervention 2018; 14: e443\u201351","DOI":"10.4244\/EIJ-D-17-01111"},{"key":"10.3238\/arztebl.2020.0320_ref35","doi-asserted-by":"crossref","unstructured":"Kubo T, Shinke T, Okamura T, et al.: Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J 2017; 38: 3139\u201347","DOI":"10.1093\/eurheartj\/ehx351"},{"key":"10.3238\/arztebl.2020.0320_ref36","doi-asserted-by":"crossref","unstructured":"Ali ZA, Maehara A, G\u00e9n\u00e9reux P, et al.: Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet 2016; 388: 2618\u201328","DOI":"10.1016\/S0140-6736(16)31922-5"},{"key":"10.3238\/arztebl.2020.0320_ref37","doi-asserted-by":"crossref","unstructured":"Pasceri V, Pelliccia F, Pristipino C, et al.: Clinical effects of routine postdilatation of drug-eluting stents. Catheter Cardiovasc Interv 2014; 83: 898\u2013904","DOI":"10.1002\/ccd.24999"},{"key":"10.3238\/arztebl.2020.0320_ref38","doi-asserted-by":"crossref","unstructured":"Serruys PW, Kogame N, Katagiri Y, et al.: Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study. EuroIntervention 2019; 15: e244\u201352","DOI":"10.4244\/EIJ-D-18-00980"},{"key":"10.3238\/arztebl.2020.0320_ref39","doi-asserted-by":"crossref","unstructured":"Dangas GD, Claessen BE, Mehran R, et al.: Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv 2012; 5: 1097\u2013105","DOI":"10.1016\/j.jcin.2012.07.012"},{"key":"10.3238\/arztebl.2020.0320_ref40","doi-asserted-by":"crossref","unstructured":"R\u00e4ber L, Mintz GS, Koskinas KC, et al.: Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 2018; 39: 3281\u2013300","DOI":"10.1093\/eurheartj\/ehy285"},{"key":"10.3238\/arztebl.2020.0320_ref41","unstructured":"MedMarket Diligence, LLC: Global dynamics of surgical and interventional cardiovascular procedures, 2015\u20132022. (Report #C500). MedMarket Diligence 2016."},{"key":"10.3238\/arztebl.2020.0320_ref42","doi-asserted-by":"crossref","unstructured":"Iqbal J, Sumaya W, Tatman V, et al.: Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention 2013; 9: 62\u20139","DOI":"10.4244\/EIJV9I1A10"},{"key":"10.3238\/arztebl.2020.0320_ref43","doi-asserted-by":"crossref","unstructured":"Amabile N, Trouillet C, Meneveau N, et al.: Mechanical abnormalities associated with first- and second-generation drug-eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry. Int J Cardiol 2017; 227: 161\u20135","DOI":"10.1016\/j.ijcard.2016.11.084"},{"key":"10.3238\/arztebl.2020.0320_ref44","doi-asserted-by":"crossref","unstructured":"Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L: Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701\u20136","DOI":"10.1056\/NEJM198703193161201"},{"key":"10.3238\/arztebl.2020.0320_ref45","doi-asserted-by":"crossref","unstructured":"Garg S, Serruys PW: Coronary stents: current status. J Am Coll Cardiol 2010; 56: S1\u201342","DOI":"10.1016\/j.jacc.2010.06.007"},{"key":"10.3238\/arztebl.2020.0320_ref46","doi-asserted-by":"crossref","unstructured":"Chen KY, Rha SW, Li YJ, et al.: Comparisons of everolimus and paclitaxel-eluting stents in patients with acute myocardial infarction. J Interv Cardiol 2015; 28: 147\u201356","DOI":"10.1111\/joic.12187"},{"key":"10.3238\/arztebl.2020.0320_ref47","doi-asserted-by":"crossref","unstructured":"Stefanini GG, Taniwaki M, Windecker S: Coronary stents: novel developments. Heart 2014; 100: 1051\u201361","DOI":"10.1136\/heartjnl-2012-303522"},{"key":"10.3238\/arztebl.2020.0320_ref48","doi-asserted-by":"crossref","unstructured":"Yin Y, Zhang Y, Zhao X: Safety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trials. PLoS One 2014; 9: e99648","DOI":"10.1371\/journal.pone.0099648"},{"key":"10.3238\/arztebl.2020.0320_ref49","doi-asserted-by":"crossref","unstructured":"Haude M, Ince H, Abizaid A, et al.: Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. Eur Heart J 2016; 37: 2701\u20139","DOI":"10.1093\/eurheartj\/ehw196"},{"key":"10.3238\/arztebl.2020.0320_ref50","doi-asserted-by":"crossref","unstructured":"Bansilal S, Bonaca MP, Cornel JH, et al.: Ticagrelor for secondary prevention of atherothrombotic events in patients with multivessel coronary disease. J Am Coll Cardiol 2018; 71: 489\u201396","DOI":"10.1016\/j.jacc.2017.11.050"},{"key":"10.3238\/arztebl.2020.0320_ref51","unstructured":"Deutsche Gesellschaft f\u00fcr Kardiologie \u2013 Herz-und Kreislaufforschung e.V.: ESC pocket guidelines. Duale antithrombozyt\u00e4re Therapie (DAPT) bei Koronarer Herzkrankheit. Version 2017. Gr\u00fcndwald: B\u00f6rm Bruckmeier Verlag GmbH 2018."},{"key":"10.3238\/arztebl.2020.0320_ref52","doi-asserted-by":"crossref","unstructured":"Poon EKW, Thondapu V, Hayat U, et al.: Elevated blood viscosity and microrecirculation resulting from coronary stent malapposition. J Biomech Eng 2018; 140: doi: 10.1115\/1.4039306","DOI":"10.1115\/1.4039306"},{"key":"10.3238\/arztebl.2020.0320_ref53","doi-asserted-by":"crossref","unstructured":"Yamashita T, Sakamoto K, Tabata N, et al.: Imaging-guided PCI for event suppression in Japanese acute coronary syndrome patients: community based observational cohort registry. Cardiovasc Interv Ther 2020. doi: 10.1007\/s12928\u2013020\u201300649\u20133. [Epub ahead of print]","DOI":"10.1007\/s12928-020-00649-3"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2020.0320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T10:02:18Z","timestamp":1638784938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2020.0320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2020.0320","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}